Fate Therapeutics, Inc. (FATE): Price and Financial Metrics

Fate Therapeutics, Inc. (FATE): $3.09

0.15 (+5.10%)

POWR Rating

Component Grades

Momentum

D

Stability

F

Sentiment

Quality

C

Add FATE to Watchlist
Sign Up

Industry: Biotech

Industry

F

Ranked

#177 of 328

in industry

FATE Price/Volume Stats

Current price $3.09 52-week high $8.83
Prev. close $2.94 52-week low $1.63
Day low $2.93 Volume 1,041,376
Day high $3.10 Avg. volume 2,268,398
50-day MA $3.59 Dividend yield N/A
200-day MA $4.71 Market Cap 351.74M

FATE Stock Price Chart Interactive Chart >


Fate Therapeutics, Inc. (FATE) Company Bio


Fate Therapeutics, Inc., a clinical-stage biopharmaceutical company, discovers and develops programmed cellular immunotherapies for cancer and immune disorders in the United States. The company was founded in 2007 and is based in San Diego, California.


FATE Latest News Stream


Event/Time News Detail
Loading, please wait...

FATE Latest Social Stream


Loading social stream, please wait...

View Full FATE Social Stream

FATE Price Returns

1-mo N/A
3-mo N/A
6-mo N/A
1-year N/A
3-year N/A
5-year N/A
YTD N/A
2023 N/A
2022 N/A
2021 N/A
2020 N/A
2019 N/A

Continue Researching FATE

Here are a few links from around the web to help you further your research on Fate Therapeutics Inc's stock as an investment opportunity:

Fate Therapeutics Inc (FATE) Stock Price | Nasdaq
Fate Therapeutics Inc (FATE) Stock Quote, History and News - Yahoo Finance
Fate Therapeutics Inc (FATE) Stock Price and Basic Information | MarketWatch

Get Free Updates

Join thousands of investors who get the latest news, insights and top rated picks from StockNews.com!